SCHEMBL21667275

SCHEMBL21667275

CC(CC(F)(F)F)n1c(=O)cc(NCc2ccccc2)[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2B6 P20813 1/20 0.44
▸ CDC25B P30305 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PIK3CB P42338 2/20 0.39
▸ FABP4 P15090 1/20 0.39
▸ PIK3CA P42336 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667277 0.86 SMN1; SMN2 (0.49) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL21667210 0.84 SMN1; SMN2 (0.47) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL20716038 0.84 CYP3A4 (0.61) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL16320673 0.81 CYP3A4 (0.70) SMN1; SMN2TP53CYP3A4CYP2B6MEN1
SCHEMBL21667273 0.81 SMN1; SMN2 (0.44) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL21667361 0.79 SMN1; SMN2 (0.49) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL21667214 0.78 SMN1; SMN2 (0.47) SMN1; SMN2TP53CDC25BMEN1KMT2A
SCHEMBL21667278 0.78 SMN1; SMN2 (0.45) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL21667373 0.77 SMN1; SMN2 (0.46) SMN1; SMN2TP53CYP3A4CYP2B6CDC25B
SCHEMBL21667352 0.76 KMT2A (0.41) SMN1; SMN2TP53CYP3A4CYP2B6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback